首页> 外文OA文献 >Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience

【2h】

Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience

机译：转移性胃癌和食管癌中的生物标志物驱动治疗：现实生活临床经验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ofer Purim; Alexander Beny; Moshe Inbar; Katerina Shulman; Baruch Brenner; Elizabeth Dudnik; Felix Bokstein; Mark Temper; Dror Limon; Diana Matceyevsky; David Sarid; Amiel Segal; Valeriya Semenisty; Ronen Brenner; Tamar Peretz; Efraim Idelevich; Sharon Pelles-Avraham; Amichay Meirovitz; Arie Figer; Kenneth Russell; Andreas Voss; Addie Dvir; Lior Soussan-Gutman; Ayala Hubert;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience [J] . Ofer Purim, Alexander Beny, Moshe Inbar, Targeted oncology . 2018,第2期

机译：转移性胃癌和食管癌的生物标志物驱动治疗：现实生活临床经验
2. MODUL-a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach [J] . Schmoll Hans-Joachim, Arnold Dirk, de Gramont Aimery, Journal of Cancer Research and Clinical Oncology . 2018,第6期

机译：Modul-在转移结直肠癌一线标准诱导治疗后的生物标志物驱动维持治疗的多中心随机临床试验：一种适应性的信号寻求方法
3. Real-world Treatment Patterns and Clinical Outcomes Across Lines of Therapy in Patients With Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer [J] . Clinical colorectal cancer . 2020,第1期

机译：患有先进/转移性胃或胃食管连接癌症患者的实际治疗模式和临床结果
4. Weekly Paclitaxel Therapy as the Second-line Chemotherapy to TS-1 for Advanced/Metastatic Gastric Cancer [C] . M. Fujishima, H. Imamura, H. Furukawa, International Gastric Cancer Congress . 2005

机译：每周紫杉醇治疗作为先进/转移性胃癌的二线化学疗法至TS-1
5. Dietary factors and risk of subtypes of esophageal and gastric cancer. [D] . Silvera, Stephanie Anne Navarro. 2004

机译：饮食因素和食管和胃癌亚型的风险。
6. Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience [O] . Ofer Purim, Alexander Beny, Moshe Inbar, -1

机译：生物标志物驱动的转移性胃癌和食道癌治疗：现实生活中的临床经验
7. The Impact of Clinical Features on Efficacy and Safety of the Combination of Ramucirumab and Paclitaxel for Metastatic Gastro-Oesophageal Junction/ Gastric Cancer: Data of a Real Life Experience in an Italian Institution [O] . Emanuele Vita, Antonia Strippoli, Vincenzo Di Noia, 2018

机译：一个真实的生活体验的数据在意大利的机构：在功效和Ramucirumab和紫杉醇的组合治疗转移性胃食管交界处/胃癌的临床安全性特点的影响

Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience

著录项

引文网络

相似文献

相关主题

期刊订阅